NSE filing, NSE: BOHRAIND. Summary written from the filing by ALFA Finder's alert engine.
Bohra Industries Ltd: key numbers
- Share price
- ₹13.46
- Market cap
- ₹28.50 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-2.97 Cr
- P/E (TTM)
- -9.6×Sector 9.6×
- Promoter holding
- 33.39%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bohra Industries Ltd
All →Bohra Industries Other Announcement
Bohra Industries Limited filed the Regulation 74(5) certificate for the quarter ended September 30, 2026. The RTA confirmed no rematerialization requests were received.
Bohra Industries Price Movement Clarification
Bohra Industries Limited clarified that recent stock price movements are purely market-driven, confirming they are unaware of any undisclosed material information.
Bohra Industries Annual General Meeting
Bohra Industries Limited held its 30th Annual General Meeting on September 29, 2026, adopting financial statements and regularizing the appointments of two independent directors.
Bohra Industries Annual General Meeting
Bohra Industries Limited has scheduled its 30th Annual General Meeting on September 29, 2026, through video conferencing to conduct its annual business.
Bohra Industries Board Meeting Outcome
Bohra Industries' board regularized two independent directors and noted a director's resignation. The 30th AGM date and logistics were also approved.
Bohra Industries Management Change
Bohra Industries Limited has appointed Mr. Kuncheria Palampoikayil Isaac and Mr. Ankaj Kumar Mishra as Additional Non-Executive Independent Directors, effective August 14, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.